Compare Mutual Funds

Pros
Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons

-

-

INDMoney rank
3/8
6/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

10 Years 3 Months

13 Years 3 Months

Fund AUM

₹1311 Cr

₹8265 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.62%

0.92%

Exit Load

0.25%

1%

Benchmark Index

Nifty Pharma TR INR

BSE Healthcare TR INR

No of Holdings

38

39

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(7.88%)
  2. Max Healthcare Institute Ltd Ordinary Shares(5.87%)
  3. Abbott India Ltd(5.48%)
  4. Divi's Laboratories Ltd(5.01%)
  5. HealthCare Global Enterprises Ltd(4.84%)
  1. Sun Pharmaceuticals Industries Ltd(13.02%)
  2. Lupin Ltd(7.36%)
  3. Divi's Laboratories Ltd(6.58%)
  4. Cipla Ltd(6.39%)
  5. Dr Reddy's Laboratories Ltd(6.02%)
No of Sectors

2

1

Top 3 Sectors
  1. Health(96.27%)
  2. Basic Materials(3.73%)

Health

(100%)

Equity %

98.69%

97.37%

Debt %

-

-

P/E

42.03

35.17

P/B

6.88

5.57

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

-4.7%

-2.84%

3-Month Return

-6.29%

-3.72%

6-Month Return

-4.33%

-2.78%

1-Year Return

-1.97%

1.67%

3-Year Return

23.41%

23.25%

5-Year Return

15.44%

15.04%

Sharpe

0.93

0.97

Alpha

1.41

0.33

Beta

0.94

0.9

Standard Deviation

16.37

15.32

Information Ratio

0.21

-0.32

Description

Tata India Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Rajat Srivastava

Sailesh Raj Bhan, Divya Sharma, Kinjal Desai, Lokesh Maru

Most Popular Comparisons